Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Femasys Inc. - Common Stock (NQ:FEMY)

0.3566 -0.0240 (-6.31%)

Streaming Delayed Price Updated: 4:00 PM EDT, May 15, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	242,103
Open	0.3800
Bid (Size)	0.3750 (400)
Ask (Size)	0.3800 (1,500)
Prev. Close	0.3806
Today's Range	0.3566 - 0.3855
52wk Range	0.3067 - 1.110
Shares Outstanding	11,813,610
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Femasys Expands Fertility Care Portfolio in Europe with CE Mark Approval for FemHSG™ Catheter

May 13, 2026

-- New catheter complements FemVue® and supports streamlined in-office fertility evaluation --

From Femasys Inc.

Via GlobeNewswire

Femasys Announces Financial Results for Quarter Ended March 31, 2026 and Provides Corporate Update

May 08, 2026

-- With fertility rates at historic lows, Femasys advances access to early infertility care through FemaSeed® Complete, enabling OB/GYNs to treat patients within their own practices --

From Femasys Inc.

Via GlobeNewswire

Performance

YTD	-44.0%	-44.0%
1 Month	-15.3%	-15.3%
3 Month	-27.9%	-27.9%
6 Month	-55.2%	-55.2%
1 Year	-66.4%	-66.4%

More News

Femasys Enables OB/GYNs to Deliver First-Line Fertility Treatment with Initial Commercial Use of FemaSeed® Complete

May 05, 2026

From Femasys Inc.

Via GlobeNewswire

Femasys Launches FemaSeed® Complete for OB/GYNs at ACOG 2026

April 22, 2026

From Femasys Inc.

Via GlobeNewswire

Femasys Drives International Growth with Israeli Market Entry for Fertility Portfolio

April 16, 2026

From Femasys Inc.

Via GlobeNewswire

Femasys Appoints John Canning as Chief Operating Officer to Drive Operational Execution and Advance Commercial Growth

April 01, 2026

From Femasys Inc.

Via GlobeNewswire

Femasys Announces Financial Results for Year Ended December 31, 2025 and Provides Corporate Update

March 31, 2026

From Femasys Inc.

Via GlobeNewswire

Traders are paying attention to the gapping stocks in Monday's session. ↗

March 30, 2026

Via Chartmill

Femasys Appoints Dr. Kenneth D. Eichenbaum to Board of Directors

March 18, 2026

From Femasys Inc.

Via GlobeNewswire

Femasys Advances FemBloc Toward U.S. Approval with Initiation of Pivotal Trial Enrollment

March 10, 2026

From Femasys Inc.

Via GlobeNewswire

Femasys Announces FemBloc® Permanent Birth Control Has Achieved MDSAP Certification, Advancing Global Market Access

February 26, 2026

From Femasys Inc.

Via GlobeNewswire

Femasys Receives AMA CPT Editorial Panel Approval for New Category III CPT Code for FemaSeed Intratubal Insemination

February 23, 2026

From Femasys Inc.

Via GlobeNewswire

Femasys Expands European Commercial Footprint with Swiss Partner for FemBloc, FemaSeed, and Portfolio Products

February 03, 2026

From Femasys Inc.

Via GlobeNewswire

Femasys Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement

January 14, 2026

From Femasys Inc.

Via GlobeNewswire

Femasys Announces Partnership with Refuah Health Center to Expand First-Line Access to FemaSeed® in Community-Based Care

January 13, 2026

From Femasys Inc.

Via GlobeNewswire

Traders are paying attention to the gapping stocks in Monday's session. ↗

December 29, 2025

Via Chartmill

Femasys Secures U.S. FDA Clearance for Next-Generation FemVue Diagnostic Device

December 18, 2025

From Femasys Inc.

Via GlobeNewswire

Wondering what's happening in today's after-hours session? ↗

December 17, 2025

Via Chartmill

PMCB Stock Jumps 25% After Company Sells Stake In Femasys ↗

November 25, 2025

Via Stocktwits

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

November 17, 2025

Via Benzinga

Femasys Announces Third Quarter Financial Results for 2025

November 14, 2025

From Femasys Inc.

Via GlobeNewswire

Femasys Advances Global Growth with Second Partner Order for FemBloc® in Europe

November 10, 2025

From Femasys Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

November 10, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

November 07, 2025

Via Benzinga

Femasys Stock Sparks Retail Frenzy After FDA Clears Final Phase Of FemBloc Trial And $58M Financing ↗

November 04, 2025

Via Stocktwits

Frequently Asked Questions

Is Femasys Inc. - Common Stock publicly traded?

Yes, Femasys Inc. - Common Stock is publicly traded.

What exchange does Femasys Inc. - Common Stock trade on?

Femasys Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Femasys Inc. - Common Stock?

The ticker symbol for Femasys Inc. - Common Stock is FEMY on the Nasdaq Stock Market

What is the current price of Femasys Inc. - Common Stock?

The current price of Femasys Inc. - Common Stock is 0.3566

When was Femasys Inc. - Common Stock last traded?

The last trade of Femasys Inc. - Common Stock was at 05/15/26 04:00 PM ET

What is the market capitalization of Femasys Inc. - Common Stock?

The market capitalization of Femasys Inc. - Common Stock is 4.21M

How many shares of Femasys Inc. - Common Stock are outstanding?

Femasys Inc. - Common Stock has 4M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.